Princeton Global Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $312K | Buy |
4,520
+270
| +6% | +$18.6K | 0.06% | 161 |
|
2025
Q1 | $295K | Buy |
4,250
+1,469
| +53% | +$102K | 0.06% | 158 |
|
2024
Q4 | $239K | Buy |
2,781
+1,000
| +56% | +$86K | 0.04% | 180 |
|
2024
Q3 | $213K | Sell |
1,781
-148
| -8% | -$17.7K | 0.04% | 182 |
|
2024
Q2 | $275K | Buy |
1,929
+882
| +84% | +$126K | 0.06% | 147 |
|
2024
Q1 | $134K | Buy |
1,047
+307
| +41% | +$39.4K | 0.03% | 182 |
|
2023
Q4 | $76.6K | Hold |
740
| – | – | 0.02% | 221 |
|
2023
Q3 | $67.3K | Hold |
740
| – | – | 0.02% | 223 |
|
2023
Q2 | $59.9K | Hold |
740
| – | – | 0.02% | 239 |
|
2023
Q1 | $58.9K | Hold |
740
| – | – | 0.02% | 244 |
|
2022
Q4 | $50K | Hold |
740
| – | – | 0.02% | 241 |
|
2022
Q3 | $37K | Hold |
740
| – | – | 0.01% | 266 |
|
2022
Q2 | $41K | Hold |
740
| – | – | 0.01% | 269 |
|
2022
Q1 | $41K | Hold |
740
| – | – | 0.01% | 283 |
|
2021
Q4 | $41K | Hold |
740
| – | – | 0.01% | 273 |
|
2021
Q3 | $36K | Hold |
740
| – | – | 0.01% | 284 |
|
2021
Q2 | $31K | Hold |
740
| – | – | 0.01% | 299 |
|
2021
Q1 | $25K | Sell |
740
-2,400
| -76% | -$81.1K | 0.01% | 305 |
|
2020
Q4 | $110K | Hold |
3,140
| – | – | 0.04% | 190 |
|
2020
Q3 | $109K | Hold |
3,140
| – | – | 0.04% | 176 |
|
2020
Q2 | $102K | Buy |
3,140
+740
| +31% | +$24K | 0.03% | 208 |
|
2020
Q1 | $72K | Hold |
2,400
| – | – | 0.03% | 207 |
|
2019
Q4 | $69 | Hold |
2,400
| – | – | 0.03% | 214 |
|
2019
Q3 | $61K | Hold |
2,400
| – | – | 0.03% | 190 |
|
2019
Q2 | $61K | Hold |
2,400
| – | – | 0.04% | 201 |
|
2019
Q1 | $62K | Hold |
2,400
| – | – | 0.04% | 180 |
|
2018
Q4 | $55K | Buy |
+2,400
| New | +$55K | 0.05% | 154 |
|